25Nov/13

Treating deadly dog bites costs Baramulla man his lone kidney – GreaterKashmir.com


GreaterKashmir.com

Treating deadly dog bites costs Baramulla man his lone kidney
GreaterKashmir.com
Why so? “For a kidney transplant patient, immunity has to be suppressed to minimal low so that the body accepts the donor organ while immunization is exactly the opposite,” explained medicos. … The medicos said they could only find three such cases …

25Nov/13

Sonia Gandhi congratulates India's first liver transplant recipient – Parda Phash


Parda Phash

Sonia Gandhi congratulates India’s first liver transplant recipient
Parda Phash
… enjoys meals, plays football and wants to become a doctor to save lives. Sanjay’s success helped establish liver transplantation in India,” said Anupam Sibal, senior paediatric gastroenterologist in the hospital. Babulal Nagar’s judicial custody …
Sonia Gandhi felicitates liver transplant recipientBusiness Standard

all 3 news articles »

25Nov/13

UPA Chairperson Felicitates India's First Successful Liver Transplant … – PR Newswire India (press release)

UPA Chairperson Felicitates India’s First Successful Liver Transplant …
PR Newswire India (press release)
UPA Chairperson and Congress Party President, Smt. Sonia Gandhi today felicitated India’s first successful liver transplant recipient, Sanjay Kandasamy from Kancheepuram, Tamil Nadu who had undergone a liver transplant in November 1998 at Apollo …

and more »

25Nov/13

US group opposes Gilead's patenting of hepatitis C drug in India – domain-B


Hindu Business Line

US group opposes Gilead’s patenting of hepatitis C drug in India
domain-B
US drug-maker Gilead Sciences’ patent application on hepatitis C drug sofosbuvir in India is facing opposition from a US legal group I-MAK (Initiative for Medicines, Access & Knowledge) on the ground that it is old known compound and has nothing new to …
US group seeks to block Gilead drug patent in IndiaEconomic Times
US group against Gilead’s patent request in India for hepatitis C drugTopNews United States
Indian health activists move to prevent Gilead’s drug patentFinancial Times

all 94 news articles »

24Nov/13

Indian health activists move to prevent Gilead's drug patent – Financial Times


Geo News, Pakistan

Indian health activists move to prevent Gilead’s drug patent
Financial Times
The Initiative for Medicines, Access & Knowledge in India said it had filed a “pre-grant” application in Calcutta to block a patent application on the drug sofosbuvir, just as Gilead, the US pharmaceutical group that developed the medicine, won …
US group seeks to block Gilead drug patent in IndiaGeo News, Pakistan

all 68 news articles »